Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection
| Errataetall: |
CommentOn: JAMA. 2021 Apr 13;325(14):1467-1469. - PMID 33646292 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Travel medicine and infectious disease - 44(2021) vom: 15. Nov., Seite 102170 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parai, Debaprasad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 09.12.2021 Date Revised 21.12.2022 published: Print-Electronic CommentOn: JAMA. 2021 Apr 13;325(14):1467-1469. - PMID 33646292 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.tmaid.2021.102170 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331940825 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331940825 | ||
| 003 | DE-627 | ||
| 005 | 20231225214559.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tmaid.2021.102170 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1106.xml |
| 035 | |a (DE-627)NLM331940825 | ||
| 035 | |a (NLM)34653614 | ||
| 035 | |a (PII)S1477-8939(21)00211-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parai, Debaprasad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.12.2021 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: JAMA. 2021 Apr 13;325(14):1467-1469. - PMID 33646292 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVAXIN® | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a COVISHIELD™ | |
| 650 | 4 | |a Spike IgG antibody | |
| 650 | 4 | |a Vaccination | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Glycoproteins |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a ChAdOx1 nCoV-19 |2 NLM | |
| 650 | 7 | |a B5S3K2V0G8 |2 NLM | |
| 700 | 1 | |a Choudhary, Hari Ram |e verfasserin |4 aut | |
| 700 | 1 | |a Dash, Girish Chandra |e verfasserin |4 aut | |
| 700 | 1 | |a Sahoo, Subrat Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Pattnaik, Matrujyoti |e verfasserin |4 aut | |
| 700 | 1 | |a Rout, Usha Kiran |e verfasserin |4 aut | |
| 700 | 1 | |a Nanda, Rashmi Ranjan |e verfasserin |4 aut | |
| 700 | 1 | |a Kanungo, Srikanta |e verfasserin |4 aut | |
| 700 | 1 | |a Kshatri, Jaya Singh |e verfasserin |4 aut | |
| 700 | 1 | |a Pati, Sanghamitra |e verfasserin |4 aut | |
| 700 | 1 | |a Bhattacharya, Debdutta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Travel medicine and infectious disease |d 2003 |g 44(2021) vom: 15. Nov., Seite 102170 |w (DE-627)NLM16457655X |x 1873-0442 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2021 |g day:15 |g month:11 |g pages:102170 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tmaid.2021.102170 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2021 |b 15 |c 11 |h 102170 | ||